Analyst Chad Mabry works at B. RILEY and is focused on Energy, Healthcare sectors with 46 price targets and ratings documented since 2014 spanning on 6 stocks. Previously, Chad Mabry worked at MLV. Analyst's average stock valuation to be materialised ratio is 23.33% with an average time for price targets to be met of 325.5 days.
Most recent stock forecast was given on ALT, Altimmune, Inc at 07-Sep-2021.
Chad Mabry best performing recommendations are on ESTE (EARTHSTONE ENERGY, INC).
The best stock recommendation documented was for ESTE (EARTHSTONE ENERGY, INC) at 5/11/2016. The price target of $15 was fulfilled within 14 days with a profit of $3.35 (28.76%) receiving and performance score of 20.54.
Average potential price target upside
Currently, out of the existing stock ratings of Chad Mabry - 3332 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
44
$11.48 (35.30%)
53
2 days ago
10/19 (52.63%)
$10.97 (26.68%)
30
Buy
60
$27.48 (84.50%)
72
7 days ago
4/11 (36.36%)
$16.06 (35.18%)
35
Buy
52
$19.48 (59.90%)
94
1 months 8 days ago
15/22 (68.18%)
$15.17 (29.20%)
124
Buy
59
$26.48 (81.43%)
70
2 months 19 days ago
4/9 (44.44%)
$14.51 (30.39%)
14
Sell
57
$24.48 (75.28%)
56
3 months 24 days ago
3/7 (42.86%)
$13.12 (31.26%)
32
